4 completed, 1 unknown. 2 Not applicable, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow this drug Literature Review of BQ 788 trials Research Report on BQ 788
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction BQ-788, BQ-123, L-Arginine - Cardiovascular Diseases, Cardiovascular Risk Factor | Phase 1 | Completed | The University of Texas at Arlington | 19 | 2018-10-01 | 2024-06-11 |
| Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes Insulin clamp, BQ123, BQ123 + BQ788 - Type2 Diabetes | Not applicable | Unknown | University of Southern Denmark | 22 | 2018-05-01 | 2021-06-01 |
| Nebivolol and the Endothelin (ET)-1 System Nebivolol, Metoprolol, Placebo - Prehypertension, Hypertension | Phase 4 | Completed | University of Colorado, Boulder | 42 | 2011-05-01 | 2019-01-02 |
| The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin Endothelin-1, BQ-123 and BQ-788 - Coronary Disease | Not applicable | Completed | University of Edinburgh | 15 | 2008-03-01 | 2024-05-17 |
| Endothelin-Receptor Blockade in Coronary Heart Disease BQ-123 and BQ-788 - Coronary Vessels, Endothelins | Phase 1 | Completed | Medical University of Vienna | 26 | 2003-05-01 | 2007-01-26 |
Coronary Disease (2) · Cardiovascular Diseases (1) · Hypertension (1) · Prehypertension (1)
Medical University of Vienna (1) · The University of Texas at Arlington (1) · University of Colorado, Boulder (1) · University of Edinburgh (1) · University of Southern Denmark (1)
United States (2) · Austria (1) · Denmark (1) · Sweden (1)
Anders Blomberg, MD (1) · Christopher A DeSouza, Ph.D. (1) · David E Newby, MD FRCP (1) · Jeremy P Langrish, MB BCh MRCP (1) · Stefan Mortensen, DMSc (1) · Thomas Neunteufl, MD (1)